Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction Surgery
1 other identifier
observational
382
1 country
1
Brief Summary
This observational study aims to develop a predictive model for the occurrence of new-onset stress urinary incontinence (SUI) after pelvic organ prolapse (POP) repair surgery in women. The primary questions it seeks to answer are: Which risk factors and anatomical characteristics predispose women to new-onset stress urinary incontinence following pelvic organ prolapse repair surgery? Female POP patients without any preoperative symptoms of urinary incontinence will receive telephone follow-ups at 3, 6, and 12 months after undergoing standard surgical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2025
CompletedFirst Submitted
Initial submission to the registry
May 16, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedMay 22, 2026
May 1, 2026
1 year
May 16, 2026
May 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pelvic floor ultrasound
From enrollment to 3 days before surgery
Secondary Outcomes (2)
Pelvic Floor Distress Inventory-20 (PFDI-20)
3 months, 6 months and 12 months after the surgery
International Consultation on Incontinence Questionnaire Short Form (ICI-Q-SF)
3 months, 6 months and 12 months after the surgery
Interventions
Participants will be required to complete the PFDI-20 and ICI-Q-SF questionnaires verbally during telephone follow-ups. If postoperative de novo SUI is highly suspected, participants will be advised to attend an outpatient clinic for further evaluation, including a pelvic floor ultrasound examination.
Eligibility Criteria
Patients who visited the outpatient clinic of Shanghai General Hospital for pelvic organ prolapse.
You may qualify if:
- Patients with pelvic organ prolapse quantification (POP-Q) stage II or higher;
- Patients who require surgical treatment for pelvic organ prolapse;
- Patients with no evidence of urinary incontinence before surgery.
You may not qualify if:
- Patients confirmed to have urinary incontinence before surgery;
- Patients with urinary or reproductive system infections;
- Patients with a history of prior surgery for urinary incontinence;
- Patients who have undergone previous mesh repair surgery for pelvic organ prolapse;
- Patients with a history of psychiatric disorders, hearing impairment, or communication difficulties;
- Patients receiving hormone replacement therapy;
- Patients with neurodegenerative diseases such as stroke or multiple sclerosis, or neurological conditions such as spinal cord injury.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai General Hospital
Shanghai, Shanghai Municipality, 200080, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate chief physician
Study Record Dates
First Submitted
May 16, 2026
First Posted
May 22, 2026
Study Start
December 1, 2024
Primary Completion
December 18, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Raw data will be publicly available from December 31, 2028, valid for 3 years
- Access Criteria
- After obtaining permission from the project principal investigator via email, access to the IPD public website login will be granted.
all IPD collected throughout the trial